MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma

Oral Oncology ◽  
2022 ◽  
Vol 124 ◽  
pp. 105666
Author(s):  
Rika Noji ◽  
Yoshihito Kano ◽  
Hideaki Hirai ◽  
Iichiroh Onishi ◽  
Naoto Nishii ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Recurrent Head

scholarly journals Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes

Oncotarget ◽  
2017 ◽  
Vol 8 (33) ◽  
pp. 55600-55612 ◽  
Author(s):  
Jer-Hwa Chang ◽  
Chia-Che Wu ◽  
Kevin Sheng-Po Yuan ◽  
Alexander T.H. Wu ◽  
Szu-Yuan Wu
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Treatment Outcomes ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Recurrent Head
Sign in / Sign up

Export Citation Format

Share Document